Intravenous glutamine for severe acute pancreatitis: A meta-analysis

Table 1 Characteristics of the studies included in meta-analysis on glutamine dipeptide for severe acute pancreatitis

Study	Hajdú et al[8]	Han et al[9]	He et al[10]	Fuentes-Orozco et al[11]
No. of patients included	45	60	41	44
Mean age	No significant difference	No significant difference	No significant difference	No significant difference
Male/female	No significant difference	No significant difference	No significant difference	No significant difference
Body mass index on admission	No significant difference	No significant difference	No significant difference	No significant difference
Plasma glutamine levels on admission	No significant difference	No significant difference	No significant difference	No significant difference
Patients (Gln/Con)	24/21	32/28	20/21	22/22
Gln dipeptide	0.5 g/kg per day, intravenously	20 g/d, intravenously	0.4 g/kg per day, intravenously	0.4 g/kg per day, intravenously
Days of Gln (d) admininistration	7	7	14	10
Randomization	Yes	Yes	Yes	Yes
Allocation concealment	Yes	Yes	Yes	Yes
Double blinding	Yes	Yes	Yes	Yes
ITT analysis	Yes	Yes	Yes	Yes

Gln: Glutamine.